ROHTO PHARMACEUTICAL CO LTD (RPHCF:OTCMKTS)
$15 -0.2 (-1.3158%)
Analysed ROHTO PHARMACEUTICAL CO LTD (RPHCF:OTCMKTS) News Sources
Rohto Pharmaceutical (TSE:4527): Assessing Valuation Signals After Recent Market Momentum
17-09-2025
yahoo.com
Is There Now an Opportunity in Rohto Shares After 26% Drop in the Past Year?
18-09-2025
yahoo.com
Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities
14-11-2025
yahoo.com
Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials
01-12-2025
yahoo.com
Yii Partners with Japan's ANDS Corporation: Building Skin Resilience through Pharmaceutical-Grade Science
22-12-2025
yahoo.com
Asset Value Investors (AVI) Urges Rohto Pharmaceutical to Focus on Core Businesses and Engage More Constructively with Shareholders
07-05-2026
yahoo.com
Rohto Pharmaceutical (TSE:4527) Valuation After Higher Year End Dividend And New Earnings Guidance
23-05-2026
yahoo.com
What is the current price of ROHTO PHARMACEUTICAL CO LTD (RPHCF:OTCMKTS)?
The current price of ROHTO PHARMACEUTICAL CO LTD (RPHCF:OTCMKTS) is $15.
ROHTO PHARMACEUTICAL CO LTD (RPHCF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ROHTO PHARMACEUTICAL CO LTD (RPHCF:OTCMKTS) since the previous trading day is $-0.2.
ROHTO PHARMACEUTICAL CO LTD (RPHCF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ROHTO PHARMACEUTICAL CO LTD (RPHCF:OTCMKTS) since the previous trading day is -1.3158%.
What is the most recent average sentiment score for ROHTO PHARMACEUTICAL CO LTD (RPHCF:OTCMKTS)?
The most recent average sentiment score for ROHTO PHARMACEUTICAL CO LTD (RPHCF:OTCMKTS) is 66 out of 100.
What is the most recent average sentiment for ROHTO PHARMACEUTICAL CO LTD (RPHCF:OTCMKTS)?
The most recent sentiment for ROHTO PHARMACEUTICAL CO LTD (RPHCF:OTCMKTS) is .
SEC-8K** Filing Available For ROHTO PHARMACEUTICAL CO LTD (RPHCF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.